Menu
Enrolling by invitation NCT07642830

Digital Health Solutions for Patients With Type 2 Diabetes

No phase Interventional Diabetes Mellitus Type 2

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: CGM.
Who it may be relevant to
Registry conditions: Diabetes Mellitus Type 2. Basic parameters: 20 years — 75 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Taiwan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Clinical Research of Digital Health Solutions for Patients With Type 2 Diabetes

Overview

We will conduct a prospective, single-center observational study involving 60 adult T2D patients recruited from Chang Gung Memorial Hospital. Participants will be randomly allocated to either a CGM group or a control group receiving standard care. The intervention group will utilize mobile apps for medication tracking, and a remote communication platform. All participants will collect clinical data-including HbA1c, Time in Range (TIR), insulin use-at baseline and 12 weeks. Patient adherence and satisfaction with CGM will also be assessed.

Interventions

  • Device CGM
    Use CGM in the glucose monitoring for CGM arm

Primary outcome measures

  • HbA1c [Time frame: From baseline to week 12]
  • TIR [Time frame: From baseline to week 12]

Eligibility criteria

Inclusion criteria

\- Patients with confirmed diagnosis of T2D for >1 year, capable of using a smartphone, and willing to sign informed consent.

Exclusion criteria

  • Patients with severe cardiac, hepatic, or renal disease; pregnant women; those participating in other experimental treatments; or unable to follow up.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Taiwan · 1 center
  • Chang Gung Memorial Hospital — Taoyuan

Identifiers

NCT: NCT07642830 · 202501413B0

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗